Removing antibody and preserving glomeruli in ANCA small-vessel vasculitis

Journal of the American Society of Nephrology

Volumn 18, Issue 7, 2007, Pages 1987-1989

  Lionaki, Sofia ^a   Falk, Ronald J ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; CREATININE; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; GLUCOCORTICOID; METHYLPREDNISOLONE; MONOCLONAL ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RITUXIMAB;

CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DIALYSIS; DISEASE COURSE; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; EDITORIAL; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LEUKOCYTE ACTIVATION; LUNG HEMORRHAGE; OUTCOMES RESEARCH; PATHOGENESIS; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; SMALL VESSEL VASCULITIS; STEROID THERAPY; TREATMENT OUTCOME; VASCULITIS;

EID: 34447270293     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2007050575     Document Type: Editorial

References (17)

1. Falk RJ, Jennette JC: ANCA are pathogenic - Oh yes they are! J Am Soc Nephrol 13: 1977-1979, 2002
2. Jennette JC, Xiao H, Falk RJ: Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 17: 1235-1242, 2006
3. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ, Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167: 39-45, 2005
4. Little MA, Smyth CL, Yadav R, Ambrose L, Cook HT, Nourshargh S, Pusey CD: Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 106: 2050-2058, 2005
5. Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ: Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 45: 758-761, 2005
6. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH: Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143: 621-631, 2005
7. Nachman PH, Hogan SL, Jennette JC, Falk RJ: Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 7: 33-39, 1996
8. Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ: Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 42: 1149-1153, 2003
9. Couser WG: Rapidly progressive glomerulonephritis: Classification, pathogenetic mechanisms, and therapy. Am J Kidney Dis 11: 449-464, 1988
10. Bolton WK, Sturgill BC: Methylprednisolone therapy for acute crescentic rapidly progressive glomerulonephritis. Am J Nephrol 9: 368-375, 1989
11. Glockner WM, Sieberth HG, Wichmann HE, Backes E, Bambauer R, Boesken WH, Bohle A, Daul A, Graben N, Keller F: Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: A controlled, multi-center study. Clin Nephrol 29: 1-8, 1988
12. Cole E, Cattran D, Magil A, Greenwood C, Churchill D, Sutton D, Clark W, Morrin P, Posen G, Bernstein K: A prospective randomized trial of plasma exchange as additive therapy in idiopathic crescentic glomerulonephritis. The Canadian Apheresis Study Group. Am J Kidney Dis 20: 261-269, 1992
13. Pusey CD, Rees AJ, Evans DJ, Peters DK, Lockwood CM: Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. Kidney Int 40: 757-763, 1991
14. Jayne DRW, Gaskin G, Rasmussen N, Abramowicz D Ferrario F, Guillevin L, Mirapeix E, Savage COS, Sinico RA, Stegeman CA, Westman KW, van der Woude FJ, Lind van Wijngaarden RAF, Pusey CD: Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18: 2180-2188, 2007
15. Nachman PH, Hogan SL, Dooley MA, Satterly KK, Jennette JC, Falk RJ; for the Glomerular Disease Collaborative Network (GDCN): Remission and relapse in ANCA small vessel vasculitis (SW) by ANCA antigen specificity and by disease category [Abstract]. J Am Soc Nephrol 8: 94A, 1997
16. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noel LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM: Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17: 2264-2274, 2006
17. de Lind van Wijngaarden RAF, Hauer HA, Wolterbeek R, Jayne DRW, Gaskin G, Rasmussen N, Noel L-H, Ferrario F, Waldherr R, Bruijn JA, Bajema IM, Hagen EC; for the European Vasculitis Study Group (EUVAS): Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis. J Am Soc Nephrol 18: 2189-2197, 2007